Takeda Cash And Equivalents vs Common Stock Analysis

TAK Stock  USD 13.57  0.13  0.97%   
Takeda Pharmaceutical financial indicator trend analysis is much more than just breaking down Takeda Pharmaceutical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Takeda Pharmaceutical is a good investment. Please check the relationship between Takeda Pharmaceutical Cash And Equivalents and its Common Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Cash And Equivalents vs Common Stock

Cash And Equivalents vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Takeda Pharmaceutical Cash And Equivalents account and Common Stock. At this time, the significance of the direction appears to have strong relationship.
The correlation between Takeda Pharmaceutical's Cash And Equivalents and Common Stock is 0.62. Overlapping area represents the amount of variation of Cash And Equivalents that can explain the historical movement of Common Stock in the same time period over historical financial statements of Takeda Pharmaceutical Co, assuming nothing else is changed. The correlation between historical values of Takeda Pharmaceutical's Cash And Equivalents and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Equivalents of Takeda Pharmaceutical Co are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Cash And Equivalents i.e., Takeda Pharmaceutical's Cash And Equivalents and Common Stock go up and down completely randomly.

Correlation Coefficient

0.62
Relationship DirectionPositive 
Relationship StrengthSignificant

Cash And Equivalents

Common Stock

Most indicators from Takeda Pharmaceutical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Takeda Pharmaceutical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At this time, Takeda Pharmaceutical's Sales General And Administrative To Revenue is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 18.12 this year, although the value of Selling General Administrative will most likely fall to about 783 B.
 2021 2022 2023 2024 (projected)
Interest Expense166.6B169.7B119.5B125.5B
Depreciation And Amortization583.2B664.4B728.0B764.4B

Takeda Pharmaceutical fundamental ratios Correlations

-0.140.990.960.960.980.98-0.080.98-0.310.690.131.00.490.320.780.99-0.580.980.980.870.850.990.90.910.58
-0.14-0.05-0.16-0.07-0.25-0.29-0.1-0.09-0.11-0.140.4-0.16-0.490.080.06-0.120.03-0.04-0.16-0.46-0.3-0.05-0.380.190.31
0.99-0.050.920.960.940.95-0.050.99-0.350.680.140.990.460.310.790.99-0.60.990.960.820.830.990.840.920.65
0.96-0.160.920.930.960.96-0.220.91-0.350.670.140.960.450.320.680.95-0.60.920.950.880.820.930.920.850.48
0.96-0.070.960.930.920.93-0.150.96-0.330.740.10.960.390.20.750.95-0.640.940.950.80.760.970.850.880.73
0.98-0.250.940.960.921.0-0.180.95-0.290.640.00.980.620.260.670.97-0.540.920.990.940.910.930.970.830.49
0.98-0.290.950.960.931.0-0.140.96-0.310.680.00.980.610.250.690.97-0.570.930.980.940.910.940.960.820.49
-0.08-0.1-0.05-0.22-0.15-0.18-0.14-0.090.14-0.050.36-0.09-0.180.280.34-0.050.140.04-0.2-0.16-0.22-0.01-0.310.06-0.27
0.98-0.090.990.910.960.950.96-0.09-0.340.680.040.980.530.230.750.98-0.590.970.970.850.860.980.870.880.66
-0.31-0.11-0.35-0.35-0.33-0.29-0.310.14-0.34-0.37-0.15-0.32-0.02-0.20.06-0.380.44-0.32-0.32-0.2-0.4-0.32-0.31-0.23-0.18
0.69-0.140.680.670.740.640.68-0.050.68-0.370.080.70.12-0.020.570.68-0.460.690.630.530.450.710.620.630.43
0.130.40.140.140.10.00.00.360.04-0.150.080.1-0.610.80.430.16-0.140.25-0.01-0.22-0.220.21-0.150.43-0.04
1.0-0.160.990.960.960.980.98-0.090.98-0.320.70.10.50.290.770.99-0.590.980.980.880.860.980.910.890.57
0.49-0.490.460.450.390.620.61-0.180.53-0.020.12-0.610.5-0.130.10.47-0.110.380.610.780.810.390.680.220.15
0.320.080.310.320.20.260.250.280.23-0.2-0.020.80.29-0.130.370.340.00.380.240.110.140.340.140.48-0.09
0.780.060.790.680.750.670.690.340.750.060.570.430.770.10.370.78-0.40.850.670.530.420.830.510.880.46
0.99-0.120.990.950.950.970.97-0.050.98-0.380.680.160.990.470.340.78-0.60.980.970.860.860.990.890.90.55
-0.580.03-0.6-0.6-0.64-0.54-0.570.14-0.590.44-0.46-0.14-0.59-0.110.0-0.4-0.6-0.57-0.56-0.48-0.53-0.59-0.52-0.48-0.51
0.98-0.040.990.920.940.920.930.040.97-0.320.690.250.980.380.380.850.98-0.570.930.780.781.00.810.940.59
0.98-0.160.960.950.950.990.98-0.20.97-0.320.63-0.010.980.610.240.670.97-0.560.930.910.910.950.940.850.59
0.87-0.460.820.880.80.940.94-0.160.85-0.20.53-0.220.880.780.110.530.86-0.480.780.910.920.80.960.650.33
0.85-0.30.830.820.760.910.91-0.220.86-0.40.45-0.220.860.810.140.420.86-0.530.780.910.920.780.920.630.4
0.99-0.050.990.930.970.930.94-0.010.98-0.320.710.210.980.390.340.830.99-0.591.00.950.80.780.830.940.63
0.9-0.380.840.920.850.970.96-0.310.87-0.310.62-0.150.910.680.140.510.89-0.520.810.940.960.920.830.680.39
0.910.190.920.850.880.830.820.060.88-0.230.630.430.890.220.480.880.9-0.480.940.850.650.630.940.680.6
0.580.310.650.480.730.490.49-0.270.66-0.180.43-0.040.570.15-0.090.460.55-0.510.590.590.330.40.630.390.6
Click cells to compare fundamentals

Takeda Pharmaceutical Account Relationship Matchups

Takeda Pharmaceutical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets12.8T12.9T13.2T14.0T15.1T15.9T
Common Stock Shares Outstanding1.6B1.6B1.6B1.6B1.6B1.3B
Short Long Term Debt Total5.1T4.6T4.3T4.4T5.5T5.7T
Other Current Liab682.3B1.3T1.4T1.5T1.4T1.5T
Total Current Liabilities2.2T1.8T2.1T2.5T2.3T2.4T
Total Stockholder Equity4.7T5.2T5.7T6.4T7.3T7.6T
Property Plant And Equipment Net1.4T1.5T1.6T1.7T2.0T2.1T
Current Deferred Revenue119.5B588.0B616.5B109.9B126.4B120.1B
Net Debt4.5T3.7T3.5T3.8T5.3T5.5T
Retained Earnings1.4T1.5T1.5T1.5T1.4T1.4T
Accounts Payable318.8B232.1B295.9B307.5B320.0B187.0B
Cash637.6B966.2B849.7B533.5B205.2B194.9B
Non Current Assets Total10.4T10.2T10.6T11.6T12.6T13.2T
Non Currrent Assets Other103.8B100.3B82.6B63.3B785.9B825.1B
Cash And Short Term Investments653.4B1.0T875B553.7B457.8B722.1B
Net Receivables784.9B812.7B724.4B681.7B612.4B545.5B
Common Stock Total Equity168.7B1.6T1.7T1.7T1.9T2.0T
Short Term Investments15.8B36.6B25.3B20.2B15.1B14.3B
Liabilities And Stockholders Equity12.8T12.9T13.2T14.0T15.1T15.9T
Non Current Liabilities Total5.9T6.0T5.3T5.1T5.5T5.8T
Inventory759.6B753.9B853.2B986.5B1.2T1.3T
Other Current Assets114.2B180.1B166.4B196.3B278.5B292.4B
Other Stockholder Equity1.6T1.6T1.6T1.6T4.2T4.4T
Total Liab8.1T7.7T7.5T7.6T7.8T8.2T
Property Plant And Equipment Gross1.4T1.5T2.5T2.7T3.2T3.4T
Total Current Assets2.5T2.7T2.6T2.4T2.6T2.0T
Accumulated Other Comprehensive Income92.6B366.1B934.2B1.5T2.5T2.6T
Short Term Debt586.8B72.3B257.9B399.2B433.5B455.1B
Common Stock1.7T1.7T1.7T1.7T1.7T1.8T
Good Will4.0T4.0T4.4T4.8T5.4T5.7T
Intangible Assets4.2T3.9T3.8T4.3T4.3T2.3T
Other Assets10.4T454.1B678.7B429.3B493.7B469.0B
Other Liab1.1T831.0B1.2T544.1B625.7B713.1B
Net Tangible Assets(3.8T)(3.5T)(2.8T)(2.5T)(2.3T)(2.4T)
Long Term Debt4.5T4.6T4.1T4.0T4.5T3.1T
Long Term Investments369.5B348.4B330.1B378.9B430.6B305.1B
Short Long Term Debt586.8B22.2B204.0B339.6B367.3B335.6B
Treasury Stock(74.4B)(57.1B)(87.5B)(59.6B)(53.6B)(56.3B)
Property Plant Equipment1.4T1.5T1.6T1.7T1.9T1.1T
Long Term Debt Total4.5T4.6T4.1T4.0T4.6T3.3T

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Takeda Pharmaceutical is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Takeda Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Takeda Pharmaceutical Co Stock. Highlighted below are key reports to facilitate an investment decision about Takeda Pharmaceutical Co Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.049
Dividend Share
192
Earnings Share
0.59
Revenue Per Share
1.4 K
Quarterly Revenue Growth
0.127
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.